S635-2636 Screening compound: {8-[(1-ethyl-3-methyl-1H-pyrazol-4-yl)methyl]-2-(pyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-4-yl}methanol

S635-2636 Screening compound: {8-[(1-ethyl-3-methyl-1H-pyrazol-4-yl)methyl]-2-(pyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-4-yl}methanol
S635-2636 Screening compound: {8-[(1-ethyl-3-methyl-1H-pyrazol-4-yl)methyl]-2-(pyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-4-yl}methanol alternative view

Chemical Structure Depiction of ChemDiv screening compound S635-2636
{8-[(1-ethyl-3-methyl-1H-pyrazol-4-yl)methyl]-2-(pyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-4-yl}methanol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S635-2636

Molecular Formula

C20H30N6O (C20 H30 N6 O)

Compound Name

{8-[(1-ethyl-3-methyl-1H-pyrazol-4-yl)methyl]-2-(pyrimidin-4-yl)-2,8-diazaspiro[4.5]decan-4-yl}methanol

IUPAC name

{8-[(1-ethyl-3-methyl-1H-pyrazol-4-yl)methyl]-2-(pyrimidin-4-yl)-28-diazaspiro[4.5]decan-4-yl}methanol

SMILES

CCn1nc(C)c(CN(CC2)CCC2(C2)C(CO)CN2c2ncncc2)c1

InChI

InChI=1S/C20H30N6O/c1-3-26-11-17(16(2)23-26)10-24-8-5-20(6-9-24)14-25(12-18(20)13-27)19-4-7-21-15-22-19/h4,7,11,15,18,27H,3,5-6,8-10,12-14H2,1-2H3/t18-/m1/s1

InChI Key

DXNYKFSYYCKAFT-GOSISDBHSA-N

MDL Number (MFCD)

MFCD29017067

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.5

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.161

Distribution Coefficient, logD

-4.220

Water Solubility, LogSw

-0.48

Polar Surface Area

59.009

Acid Dissociation Constant (pKa)

15.96

Base Dissociation Constant (pKb)

12.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

65.00

S635-2636 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with S635-2636 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S635-2636?
Check Price and Availability of S635-2636, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S635-2636 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S635-2636
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S635-2636
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S635-2636 available by request